OXYGENTA PHARMACEUTICAL Announcements
Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015.
26 Sep, 2025 | 07:06pm • Source: BSE
Secrutinzers Report and Voting Results for AGM held on 19.09.2025
19 Sep, 2025 | 08:52pm • Source: BSE
Outcome of the 32nd Annual General Meeting of the Company.
19 Sep, 2025 | 08:48pm • Source: BSE
Intimation of submission of application to BSE Limited for reclassification of promoters
29 Aug, 2025 | 04:09pm • Source: BSE
Book Closure Intimation for the Annual General Meeting for the Financial Year 2024-25 scheduled to be held on 19.09.2025.
28 Aug, 2025 | 06:02pm • Source: BSE
Submission of 32nd Annual Report for the Financial Year 2024-25 under Regulation 34 of SEBI (LODR) Regulations, 2015.
28 Aug, 2025 | 05:57pm • Source: BSE
Submission of Notice of 32nd Annual General meeting for the Finanical Year 2024-25.
28 Aug, 2025 | 05:53pm • Source: BSE
Board approved reclassification request received to change the status from Promoter to Public shareholder.
25 Aug, 2025 | 06:14pm • Source: BSE
Intimation of receipt of request applications from promoters for reclassification in accordanxce with Reg. 31A of SEBI (LODR) Regulations, 2015
19 Aug, 2025 | 06:20pm • Source: BSE
Revised Intimation under reg 30 of SEBI LODR Regulations, 2015
19 Aug, 2025 | 11:13am • Source: BSE
Disclosure under Regulation 30 of SEBI (LODR) Regualtions, 2015
18 Aug, 2025 | 06:11pm • Source: BSE
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
18 Aug, 2025 | 06:09pm • Source: BSE
Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and...
11 Aug, 2025 | 05:48pm • Source: BSE
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2025.
21 Jul, 2025 | 05:58pm • Source: BSE
Treading window Closure for the Quarter ending 30th June 2025
30 Jun, 2025 | 02:36pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virupaksha Organics Ltd
23 Jun, 2025 | 12:53pm • Source: BSE
Additional Discoursers required for Resignation of Independent directors in continuation with the disclosure given yesterday i.e on June 20, 2025
21 Jun, 2025 | 03:53pm • Source: BSE
We hereby attaching you the intimation under regulation 31A(10) of SEBI(LODR) Regulation, 2015 for reclassification of promoter to public pursuant to open offer.
20 Jun, 2025 | 10:09pm • Source: BSE
We hereby attaching you the BM outcome
20 Jun, 2025 | 10:00pm • Source: BSE